Linked Life Data

19434749

Source:http://linkedlifedata.com/resource/pubmed/id/19434749

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2009-12-9
pubmed:abstractText
The MGuard stent has been designed as a plaque trapping device to treat athero-thrombotic lesions in saphenous vein grafts and native coronary lesions. It was utilized in seven coronary bypass patients to treat eight vein grafts. The average graft age was 15 years. Procedural success was 100% without any intraprocedural, in-hospital, and/or 30-day major adverse cardiac events (e.g. death, myocardial infarction, and need for repeat graft revascularization). No patient experienced distal embolization and/or procedure-related CK enzymatic rise. This strategy seems to be a promising approach in percutaneous vascular management of vein graft lesions.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1522-726X
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
74
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1055-7
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Preliminary experiences using the MGuard stent platform in saphenous vein graft lesions.
pubmed:affiliation
Division of Interventional Cardiology, Rabin Medical Center, Petach Tikva, and Sackler Faculty of Medicine, Tel-Aviv University, Israel.
pubmed:publicationType
Journal Article